Home » Clinical Trials » Medical Areas
Therapeutic Areas: Ophthalmology
Disease Category: Ocular Hypertension
Trial Information
Evaluation of the ocular surface health in subjects using Travatan Z versus Xalatan
To compare the effectiveness of Travatan Z versus Xalatan for ocular surface health
3 office visits over a 3 month period
Compensation for time and travel
Patient Inclusion Criteria
- Diagnosed with open-angle glaucoma or ocular hypertension
- Using Xalatan for at least 1 month with controlled eye pressure
- 18 years of age or older
Patient Exclusion Criteria
- 1.Ocular laser surgery within 3 months of enrollment
- Intraocular or extra-ocular surgery within 6 months of enrollment
- Dry eye which has been or is currently being treated with the use of punctal plugs,punctal cautery, Restasis, or topical ocular corticosteriods
Lisa Flynn or Kelleanne Miles, CRCs
Philadelphia Eye Associates
1703 South Broad Street
Philadelphia PA 19148
Phone: 215-339-8100 x 1115/1120
EMail: 215-339-0250
View Google Map
Research Center Information: Philadelphia Eye Associates
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
